The potential role of BTMs in the prediction of hypocalcemia induced by denosumab in patients with bone metastases.
Not Applicable
- Conditions
- Bone metastases
- Registration Number
- JPRN-UMIN000022516
- Lead Sponsor
- Department of Orthopaedic Surgery, Showa University School of Medicine, Tokyo, Japan
- Brief Summary
Ishikawa K, Nagai T, Tuchiya K, et al. High bone turnover status as a risk factor for symptomatic hypocalcemia following denosumab treatment in patients with osteoporosis. Clin Interv Aging. 8;13:1929-1934.2018.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded from the study if they had (1)contraindicate factors (2)hyperparathyroidism or under the pregnacy. (3)adjusted baseline serum calcium concentrations above or below the normal range in our laboratory.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method